Fair Prescription Drug Prices for Americans Act
- Last Action
- 4/19/2023
Actions
- 2023-04-19Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-04-19Introduced in Senate
CRS Summary
As of 2023-04-19 (00)
Fair Prescription Drug Prices for Americans Act
This bill caps the price of drugs and biologics at the average price among certain countries.
Specifically, the retail list price of a drug or biologic in the United States may not exceed the average retail list price among Canada, France, Germany, Italy, Japan, and the United Kingdom. The Department of Health and Human Services (HHS) must calculate the average price in these countries based on data that is submitted by manufacturers directly to HHS and on publicly filed materials from manufacturers.
Manufacturers who violate the bill's price cap are subject to civil penalties.
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.